Literature DB >> 29715498

Linking gut microbiota to cardiovascular disease and hypertension: Lessons from chronic kidney disease.

B Meijers1, F Jouret2, P Evenepoel3.   

Abstract

Bidirectional interactions exist between the kidneys and the gut. These interactions are commonly referred to as the gut-kidney axis. Chronic kidney disease (CKD) leads to disturbances of the gut ecosystem. Key features include the increase of protein fermentation at the expense of carbohydrate fermentation and a disrupted epithelial barrier. A disturbed gut ecosystem may contribute to the high burden of cardiovascular disease in patients with CKD. The present review discusses the impact of CKD on the gut microenvironment and provides an update as to how gut dysbiosis and a leaky gut may be linked to accelerated cardiovascular disease and hypertension.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cardiovascular disease; Dysbiosis; Fermentation; Hypertension; Inflammation; Microbiota

Mesh:

Year:  2018        PMID: 29715498     DOI: 10.1016/j.phrs.2018.04.023

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  16 in total

1.  Effects of Microbiota-Driven Therapy on Circulating Indoxyl Sulfate and P-Cresyl Sulfate in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Li Chen; Junhe Shi; Xiaojuan Ma; Dazhuo Shi; Hua Qu
Journal:  Adv Nutr       Date:  2022-08-01       Impact factor: 11.567

Review 2.  Metabolites and Hypertension: Insights into Hypertension as a Metabolic Disorder: 2019 Harriet Dustan Award.

Authors:  Saroj Chakraborty; Juthika Mandal; Tao Yang; Xi Cheng; Ji-Youn Yeo; Cameron G McCarthy; Camilla F Wenceslau; Lauren G Koch; Jennifer W Hill; Matam Vijay-Kumar; Bina Joe
Journal:  Hypertension       Date:  2020-04-27       Impact factor: 10.190

3.  Human Stool Metabolome Differs upon 24 h Blood Pressure Levels and Blood Pressure Dipping Status: A Prospective Longitudinal Study.

Authors:  Justine Huart; Arianna Cirillo; Bernard Taminiau; Julie Descy; Annie Saint-Remy; Georges Daube; Jean-Marie Krzesinski; Pierrette Melin; Pascal de Tullio; François Jouret
Journal:  Metabolites       Date:  2021-04-29

4.  Kidney injury-mediated disruption of intestinal lymphatics involves dicarbonyl-modified lipoproteins.

Authors:  Jianyong Zhong; Hai-Chun Yang; Valery Yermalitsky; Elaine L Shelton; Tadashi Otsuka; Carrie B Wiese; Linda S May-Zhang; Babak Banan; Naji Abumrad; Jiansheng Huang; Ashley B Cavnar; Annet Kirabo; Patricia G Yancey; Agnes B Fogo; Kasey C Vickers; MacRae F Linton; Sean S Davies; Valentina Kon
Journal:  Kidney Int       Date:  2021-06-05       Impact factor: 18.998

5.  Maternal Tryptophan Supplementation Protects Adult Rat Offspring against Hypertension Programmed by Maternal Chronic Kidney Disease: Implication of Tryptophan-Metabolizing Microbiome and Aryl Hydrocarbon Receptor.

Authors:  Chien-Ning Hsu; I-Chun Lin; Hong-Ren Yu; Li-Tung Huang; Mao-Meng Tiao; You-Lin Tain
Journal:  Int J Mol Sci       Date:  2020-06-26       Impact factor: 5.923

Review 6.  Role of Heme Oxygenases in Cardiovascular Syndromes and Co-morbidities.

Authors:  David D Haines; Arpad Tosaki
Journal:  Curr Pharm Des       Date:  2018       Impact factor: 3.116

Review 7.  Inflammation-Related Mechanisms in Chronic Kidney Disease Prediction, Progression, and Outcome.

Authors:  Simona Mihai; Elena Codrici; Ionela Daniela Popescu; Ana-Maria Enciu; Lucian Albulescu; Laura Georgiana Necula; Cristina Mambet; Gabriela Anton; Cristiana Tanase
Journal:  J Immunol Res       Date:  2018-09-06       Impact factor: 4.818

8.  Fecal microbiota characteristics of Chinese patients with primary IgA nephropathy: a cross-sectional study.

Authors:  Xiaofang Hu; Jie Du; Yuhong Xie; Qiong Huang; Yi Xiao; Juan Chen; Siyuan Yan; Zhicheng Gong; Shaxi Ouyang
Journal:  BMC Nephrol       Date:  2020-03-13       Impact factor: 2.388

9.  A journey from microenvironment to macroenvironment: the role of metaflammation and epigenetic changes in cardiorenal disease.

Authors:  Mehmet Kanbay; Aslihan Yerlikaya; Alan A Sag; Alberto Ortiz; Masanari Kuwabara; Adrian Covic; Andrzej Wiecek; Peter Stenvinkel; Baris Afsar
Journal:  Clin Kidney J       Date:  2019-09-18

10.  Alisol B 23-acetate attenuates CKD progression by regulating the renin-angiotensin system and gut-kidney axis.

Authors:  Hua Chen; Min-Chang Wang; Yuan-Yuan Chen; Lin Chen; Yan-Ni Wang; Nosratola D Vaziri; Hua Miao; Ying-Yong Zhao
Journal:  Ther Adv Chronic Dis       Date:  2020-05-20       Impact factor: 5.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.